Persistence of Symptoms and Quality of Life at 35 Days After Hospitalization for COVID-19 Infection

Overview

Journal PLoS One

Specialties General Medicine
Science

Date 2020 Dec 11

PMID 33306721

Citations 162

Authors

Laurie G Jacobs

Elli Gourna Paleoudis

Dineen Lesky-Di Bari

Themba Nyirenda

Tamara Friedman

Anjali Gupta

Lily Rasouli

Marygrace Zetkulic

Bindu Balani

Chinwe Ogedegbe

Harinder Bawa

Lauren Berrol

Nabiha Qureshi

Judy L Aschner

Affiliations

Soon will be listed here.

Abstract

Background: Characterizing the prevalence and persistence of symptoms associated with COVID-19 infection following hospitalization and their impact is essential to planning post-acute community-based clinical services. This study seeks to identify persistent COVID-19 symptoms in patients 35 days post-hospitalization and their impact on quality of life, health, physical, mental, and psychosocial function.

Methods And Findings: This prospective cohort study used the PROMIS® Instruments to identify symptoms and quality of life parameters in consecutively enrolled patients between March 22 and April 16, 2020, in New Jersey. The 183 patients (median age 57 years; 61.5% male, 54.1% white) reported persistent symptoms at 35 days, including fatigue (55.0%), dyspnea (45.3%), muscular pain (51%), associated with a lower odds rating general health (41.5%, OR 0.093 [95% CI: 0.026, 0.329], p = 0.0002), quality of life (39.8%; OR 0.116 [95% CI: 0.038, 0.364], p = 0.0002), physical health (38.7%, OR 0.055 [95% CI: 0.016, 0.193], p <0.0001), mental health (43.7%, OR 0.093 [95% CI: 0.021, 0.418], p = 0.0019) and social active role (38.7%, OR 0.095 [95% CI: 0.031, 0.291], p<0.0001), as very good/excellent, particularly adults aged 65 to 75 years (OR 8·666 [95% CI: 2·216, 33·884], p = 0·0019).

Conclusions: COVID-19 symptoms commonly persist to 35 days, impacting quality of life, health, physical and mental function. Early post-acute evaluation of symptoms and their impact on function is necessary to plan community-based services.

Citing Articles

Health Preferences in Transition: Differences from Pandemic to Post-Pandemic in Valuation of COVID-19 and RSV Illness in Children and Adults.

Mercon K, Rose A, Cadham C, Gebremariam A, Pike J, Wittenberg E Children (Basel). 2025; 12(2).

PMID: 40003283 PMC: 11854640. DOI: 10.3390/children12020181.

Prevalence and risk factors for long COVID among cancer patients: a systematic review and meta-analysis.

Xu H, Lu T, Liu Y, Yang J, Ren S, Han B Front Oncol. 2025; 14:1506366.

PMID: 39882453 PMC: 11774732. DOI: 10.3389/fonc.2024.1506366.

Impact of the COVID-19 Pandemic on Subjective Well-Being and Quality of Life: A Comprehensive Bibliometric and Thematic Analysis.

Aytekin A, Ayaz R, Ayaz A Health Care Anal. 2024; .

PMID: 39738823 DOI: 10.1007/s10728-024-00507-w.

The Assessment of Muscle Strength and Cardiorespiratory Parameters Using Simple Tests in Older Adults With Recovery From Mild COVID-19.

Amput P, Wongphon S Ann Rehabil Med. 2024; 48(6):389-395.

PMID: 39654436 PMC: 11703608. DOI: 10.5535/arm.240033.

Surface-Enhanced Raman Scattering Combined with Machine Learning for Rapid and Sensitive Detection of Anti-SARS-CoV-2 IgG.

Silva T, Dos Santos G, Prado A, Cavalieri D, Leal Junior A, Pereira F Biosensors (Basel). 2024; 14(11).

PMID: 39589982 PMC: 11591781. DOI: 10.3390/bios14110523.

References

Harris P, Taylor R, Thielke R, Payne J, Gonzalez N, Conde J . Research electronic data capture (REDCap)--a metadata-driven methodology and workflow process for providing translational research informatics support. J Biomed Inform. 2008; 42(2):377-81. PMC: 2700030. DOI: 10.1016/j.jbi.2008.08.010. View

Simmons R, Alberti K, Gale E, Colagiuri S, Tuomilehto J, Qiao Q . The metabolic syndrome: useful concept or clinical tool? Report of a WHO Expert Consultation. Diabetologia. 2009; 53(4):600-5. DOI: 10.1007/s00125-009-1620-4. View

Lam M, Wing Y, Yu M, Leung C, Ma R, Kong A . Mental morbidities and chronic fatigue in severe acute respiratory syndrome survivors: long-term follow-up. Arch Intern Med. 2009; 169(22):2142-7. DOI: 10.1001/archinternmed.2009.384. View

Guan W, Ni Z, Hu Y, Liang W, Ou C, He J . Clinical Characteristics of Coronavirus Disease 2019 in China. N Engl J Med. 2020; 382(18):1708-1720. PMC: 7092819. DOI: 10.1056/NEJMoa2002032. View

Richardson S, Hirsch J, Narasimhan M, Crawford J, McGinn T, Davidson K . Presenting Characteristics, Comorbidities, and Outcomes Among 5700 Patients Hospitalized With COVID-19 in the New York City Area. JAMA. 2020; 323(20):2052-2059. PMC: 7177629. DOI: 10.1001/jama.2020.6775. View

Gonzalez-Reiche A, Hernandez M, Sullivan M, Ciferri B, Alshammary H, Obla A . Introductions and early spread of SARS-CoV-2 in the New York City area. Science. 2020; 369(6501):297-301. PMC: 7259823. DOI: 10.1126/science.abc1917. View

Ahmed H, Patel K, Greenwood D, Halpin S, Lewthwaite P, Salawu A . Long-term clinical outcomes in survivors of severe acute respiratory syndrome and Middle East respiratory syndrome coronavirus outbreaks after hospitalisation or ICU admission: A systematic review and meta-analysis. J Rehabil Med. 2020; 52(5):jrm00063. DOI: 10.2340/16501977-2694. View

Carfi A, Bernabei R, Landi F . Persistent Symptoms in Patients After Acute COVID-19. JAMA. 2020; 324(6):603-605. PMC: 7349096. DOI: 10.1001/jama.2020.12603. View

Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y . Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020; 395(10223):497-506. PMC: 7159299. DOI: 10.1016/S0140-6736(20)30183-5. View

10.

Iannaccone S, Alemanno F, Houdayer E, Brugliera L, Castellazzi P, Cianflone D . COVID-19 rehabilitation units are twice as expensive as regular rehabilitation units. J Rehabil Med. 2020; 52(6):jrm00073. DOI: 10.2340/16501977-2704. View

11.

Gebhard C, Regitz-Zagrosek V, Neuhauser H, Morgan R, Klein S . Impact of sex and gender on COVID-19 outcomes in Europe. Biol Sex Differ. 2020; 11(1):29. PMC: 7247289. DOI: 10.1186/s13293-020-00304-9. View

12.

Cydulka R, Emerman C, Rowe B, Clark S, Woodruff P, Singh A . Differences between men and women in reporting of symptoms during an asthma exacerbation. Ann Emerg Med. 2001; 38(2):123-8. DOI: 10.1067/mem.2001.114305. View

13.

Jin J, Bai P, He W, Wu F, Liu X, Han D . Gender Differences in Patients With COVID-19: Focus on Severity and Mortality. Front Public Health. 2020; 8:152. PMC: 7201103. DOI: 10.3389/fpubh.2020.00152. View

14.

Potere N, Valeriani E, Candeloro M, Tana M, Porreca E, Abbate A . Acute complications and mortality in hospitalized patients with coronavirus disease 2019: a systematic review and meta-analysis. Crit Care. 2020; 24(1):389. PMC: 7330272. DOI: 10.1186/s13054-020-03022-1. View

15.

Keeley P, Buchanan D, Carolan C, Pivodic L, Tavabie S, Noble S . Symptom burden and clinical profile of COVID-19 deaths: a rapid systematic review and evidence summary. BMJ Support Palliat Care. 2020; 10(4):381-384. DOI: 10.1136/bmjspcare-2020-002368. View

16.

Hendren N, Drazner M, Bozkurt B, Cooper Jr L . Description and Proposed Management of the Acute COVID-19 Cardiovascular Syndrome. Circulation. 2020; 141(23):1903-1914. PMC: 7314493. DOI: 10.1161/CIRCULATIONAHA.120.047349. View

17.

Park S, Yun S, Shin J, Lee B, Son H, Lee S . Persistent severe acute respiratory syndrome coronavirus 2 detection after resolution of coronavirus disease 2019-associated symptoms/signs. Korean J Intern Med. 2020; 35(4):793-796. PMC: 7373965. DOI: 10.3904/kjim.2020.203. View

18.

Ngai J, Ko F, Ng S, To K, Tong M, Hui D . The long-term impact of severe acute respiratory syndrome on pulmonary function, exercise capacity and health status. Respirology. 2010; 15(3):543-50. PMC: 7192220. DOI: 10.1111/j.1440-1843.2010.01720.x. View

19.

Barsky A, Peekna H, Borus J . Somatic symptom reporting in women and men. J Gen Intern Med. 2001; 16(4):266-75. PMC: 1495200. View

20.

Harris P, Taylor R, Minor B, Elliott V, Fernandez M, ONeal L . The REDCap consortium: Building an international community of software platform partners. J Biomed Inform. 2019; 95:103208. PMC: 7254481. DOI: 10.1016/j.jbi.2019.103208. View